Search

Your search keyword '"Richou, Carine"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Richou, Carine" Remove constraint Author: "Richou, Carine" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
145 results on '"Richou, Carine"'

Search Results

4. Alveolar echinococcosis in solid organ transplant recipients: a case series from two national cohorts

5. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

7. Circulating cell-free DNA in patients with alveolar echinococcosis

8. Molecular diagnosis of alveolar echinococcosis in patients based on frozen and formalin-fixed paraffin-embedded tissue samples

9. Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study

10. Cabozantinib (CABO) tolerance and efficacy for patients with advanced hepatocellular carcinoma (HCC) after failure of sorafenib (SOR) in a French population: CLERANCE, a phase 4 trial.

11. Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis

13. Diagnostic de l’échinococcose alvéolaire

15. Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study

20. Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients

21. Investigating new serological and tissue markers for the follow‐up of patients operated for alveolar echinococcosis

27. Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis

28. Comparison of the serological tests ICT and ELISA for the diagnosis of alveolar echinococcosis in France☆

29. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial.

30. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

32. Préservation de la fertilité dans un contexte d'échinococcose alvéolaire avec atteinte ovarienne bilatérale : à propos d'un cas.

33. Circulating cell-free DNA in patients with alveolar echinococcosis

34. Prognostic Impact of 3-HM Concentration in Patients with Alcoholic or Viral Cirrhosis

35. Doxorubicin-Loaded Nanoparticles for Patients with Advanced Hepatocellular Carcinoma after Failure of Sorafenib: RELIVE, a Phase-3 Trial

36. BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

37. Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients

39. Increased Incidence and Characteristics of Alveolar Echinococcosis in Patients With Immunosuppression-Associated Conditions

40. Hints for control of infection in unique extrahepatic vertebral alveolar echinococcosis

42. L’échinococcose alvéolaire humaine en France en 2010 / Box – Human alveolarechinococcosis in France, update 2010

43. Em+ Elisa: a serological test able to predict long term outcome in inoperable alveolar echinococcosis patients under benzimidazole therapy

44. Increased Incidence and Characteristics of Alveolar Echinococcosis in Patients With Immunosuppression-Associated Conditions

45. Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis

46. Detecting nested clusters of human alveolar echinococcosis

Catalog

Books, media, physical & digital resources